Literature DB >> 22078485

Coronary risk correlates with cerebral amyloid deposition.

Bruce R Reed1, Natalie L Marchant, William J Jagust, Charles C DeCarli, Wendy Mack, Helena C Chui.   

Abstract

This study investigated the hypothesis that vascular risk factors are amyloidogenic. Participants were 43 persons, most with normal cognition or mild cognitive impairment. Vascular risk was quantified using the Framingham Coronary Risk Profile (FCRP) score. Cerebral amyloid was measured by [(11)C]Pittsburgh compound B (PIB) positron emission tomography (PET) and quantified with a Global PIB index, which is the average of distribution volume ratios in selected cortical regions of interest. In a bivariate model FCRP accounted for 16% of the variance in PIB index (p < 0.008) and the positive association remained significant controlling for age and sex. The effect of FCRP was independent of apolipoprotein E (APOE) genotype, which was also associated as expected with PIB. Carotid intima-media thickness was not associated with PIB index. Effects of individual FCRP component risk factors, cholesterol, and glycemic status on PIB index were all nonsignificant, suggesting an aggregate effect of risk factors. Although this is a correlational observation it may represent a causal relationship as there are multiple, plausible, amyloidogenic mechanisms of vascular risk factors. Published by Elsevier Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22078485      PMCID: PMC3371309          DOI: 10.1016/j.neurobiolaging.2011.10.002

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  66 in total

1.  Midlife blood pressure and dementia: the Honolulu-Asia aging study.

Authors:  L J Launer; G W Ross; H Petrovitch; K Masaki; D Foley; L R White; R J Havlik
Journal:  Neurobiol Aging       Date:  2000 Jan-Feb       Impact factor: 4.673

2.  Hypoxia increases Abeta generation by altering beta- and gamma-cleavage of APP.

Authors:  Liang Li; Xiaojie Zhang; Dehua Yang; Guangrui Luo; Shen Chen; Weidong Le
Journal:  Neurobiol Aging       Date:  2007-12-11       Impact factor: 4.673

Review 3.  Linking lipids to Alzheimer's disease: cholesterol and beyond.

Authors:  Gilbert Di Paolo; Tae-Wan Kim
Journal:  Nat Rev Neurosci       Date:  2011-03-30       Impact factor: 34.870

4.  15-year longitudinal study of blood pressure and dementia.

Authors:  I Skoog; B Lernfelt; S Landahl; B Palmertz; L A Andreasson; L Nilsson; G Persson; A Odén; A Svanborg
Journal:  Lancet       Date:  1996-04-27       Impact factor: 79.321

5.  Intracranial atherosclerosis as a contributing factor to Alzheimer's disease dementia.

Authors:  Alex E Roher; Suzanne L Tyas; Chera L Maarouf; Ian D Daugs; Tyler A Kokjohn; Mark R Emmerling; Zsolt Garami; Marek Belohlavek; Marwan N Sabbagh; Lucia I Sue; Thomas G Beach
Journal:  Alzheimers Dement       Date:  2011-03-09       Impact factor: 21.566

6.  Carotid intima-media thickness, plaques, and Framingham risk score as independent determinants of stroke risk.

Authors:  Pierre-Jean Touboul; Julien Labreuche; Eric Vicaut; Pierre Amarenco
Journal:  Stroke       Date:  2005-07-14       Impact factor: 7.914

7.  High total cholesterol levels in late life associated with a reduced risk of dementia.

Authors:  M M Mielke; P P Zandi; M Sjögren; D Gustafson; S Ostling; B Steen; I Skoog
Journal:  Neurology       Date:  2005-05-24       Impact factor: 9.910

8.  Blood-brain barrier impairment in Alzheimer disease: stability and functional significance.

Authors:  G L Bowman; J A Kaye; M Moore; D Waichunas; N E Carlson; J F Quinn
Journal:  Neurology       Date:  2007-05-22       Impact factor: 9.910

9.  Lacunar infarcts defined by magnetic resonance imaging of 3660 elderly people: the Cardiovascular Health Study.

Authors:  W T Longstreth; C Bernick; T A Manolio; N Bryan; C A Jungreis; T R Price
Journal:  Arch Neurol       Date:  1998-09

10.  Synthesis and evaluation of 11C-labeled 6-substituted 2-arylbenzothiazoles as amyloid imaging agents.

Authors:  Chester A Mathis; Yanming Wang; Daniel P Holt; Guo-Feng Huang; Manik L Debnath; William E Klunk
Journal:  J Med Chem       Date:  2003-06-19       Impact factor: 7.446

View more
  35 in total

1.  Cerebrovascular disease, β-amyloid, and cognition in aging.

Authors:  Natalie L Marchant; Bruce R Reed; Charles S DeCarli; Cindee M Madison; Michael W Weiner; Helena C Chui; William J Jagust
Journal:  Neurobiol Aging       Date:  2011-11-01       Impact factor: 4.673

2.  White matter lesion load is associated with resting state functional MRI activity and amyloid PET but not FDG in mild cognitive impairment and early Alzheimer's disease patients.

Authors:  Yongxia Zhou; Fang Yu; Timothy Q Duong
Journal:  J Magn Reson Imaging       Date:  2013-12-31       Impact factor: 4.813

Review 3.  A major role for cardiovascular burden in age-related cognitive decline.

Authors:  Chengxuan Qiu; Laura Fratiglioni
Journal:  Nat Rev Cardiol       Date:  2015-01-13       Impact factor: 32.419

4.  Imaging Vascular Disease and Amyloid in the Aging Brain: Implications for Treatment.

Authors:  Sylvia Villeneuve; William J Jagust
Journal:  J Prev Alzheimers Dis       Date:  2015-03

5.  Vascular Burden Score Impacts Cognition Independent of Amyloid PET and MRI Measures of Alzheimer's Disease and Vascular Brain Injury.

Authors:  Charles DeCarli; Sylvia Villeneuve; Pauline Maillard; Danielle Harvey; Baljeet Singh; Owen Carmichael; Evan Fletcher; John Olichney; Sarah Farias; William Jagust; Bruce Reed; Dan Mungas
Journal:  J Alzheimers Dis       Date:  2019       Impact factor: 4.472

6.  Cerebral Amyloid Burden and Hoehn and Yahr Stage 3 Scoring in Parkinson Disease.

Authors:  Vikas Kotagal; Nicolaas I Bohnen; Martijn L T M Müller; Kirk A Frey; Roger L Albin
Journal:  J Parkinsons Dis       Date:  2017       Impact factor: 5.568

7.  Vascular burden and Alzheimer disease pathologic progression.

Authors:  Raymond Y Lo; William J Jagust
Journal:  Neurology       Date:  2012-09-12       Impact factor: 9.910

8.  Aggregate effects of vascular risk factors on cerebrovascular changes in autopsy-confirmed Alzheimer's disease.

Authors:  Katherine J Bangen; Daniel A Nation; Lisa Delano-Wood; Gali H Weissberger; Lawrence A Hansen; Douglas R Galasko; David P Salmon; Mark W Bondi
Journal:  Alzheimers Dement       Date:  2014-07-09       Impact factor: 21.566

9.  Vascular risk and FDDNP-PET influence cognitive performance.

Authors:  David A Merrill; Prabha Siddarth; Vladimir Kepe; Pushpa V Raja; Nathan Saito; Linda M Ercoli; Karen J Miller; Helen Lavretsky; Susan Y Bookheimer; Jorge R Barrio; Gary W Small
Journal:  J Alzheimers Dis       Date:  2013       Impact factor: 4.472

10.  Impact of lifestyle dimensions on brain pathology and cognition.

Authors:  Stefanie Schreiber; Jacob Vogel; Henry D Schwimmer; Shawn M Marks; Frank Schreiber; William Jagust
Journal:  Neurobiol Aging       Date:  2016-01-30       Impact factor: 4.673

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.